NCT04525027

Brief Summary

Severe Acute Pancreatitis (SAP) is an acute inflammatory condition of the pancreas characterized by organ dysfunction and increased mortality. Increased Intra-abdominal Pressure(IAP) in SAP is a result of inflammation of pancreatic and peripancreatic tissue, aggressive fluid resuscitation and increased capillary permeability, which is associated with organ dysfunction, by limiting the vascular supply to the tissue. Abdominal Compartment Syndrome (ACS) is defined as IAP greater than 20 mm of Hg and is considered an abdominal catastrophe. Intra-abdominal Hypertension (IAH, Intra-abdominal pressure \> 12mm of Hg), may contribute to early organ dysfunction, ACS and eventually hemodynamic collapse if left untreated. This signifies the need for determining the burden of the condition and identifying the high risk patient group who are prone to develop IAH /ACS and predicting mortality associated with the condition. Measurement of IAP will be done indirectly by measuring intravesicular pressure using modified kron's method. IAP will be measured at the time of admission into Intensive Care Unit (ICU) and every day thereafter during the initial five days of ICU admission. Any reading of IAP ≥12 mm of Hg shall be considered as IAH. SOFA and APACHE II score will be noted on the day of admission in the ICU. Any interventions, surgical or non surgical as per clinician's decision will be recorded. The patients will be followed up until discharge or mortality until 30 days. The proposed study aims to assess the predictive ability of IAP during the first 5 days of ICU admission for predicting mortality in patients with SAP. Prediction accuracy will also be compared with SOFA and APACHE II scores.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
360

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 26, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 18, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 24, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2021

Completed
Last Updated

April 3, 2023

Status Verified

March 1, 2023

Enrollment Period

1.8 years

First QC Date

August 18, 2020

Last Update Submit

March 30, 2023

Conditions

Keywords

severe acute pancreatitisintra abdominal pressuremortalityintra abdominal hypertension

Outcome Measures

Primary Outcomes (1)

  • Mortality

    30 days from inclusion date

Study Arms (2)

survivors

Diagnostic Test: intra-abdominal pressure in severe acute pancreatitis

non survivors

Diagnostic Test: intra-abdominal pressure in severe acute pancreatitis

Interventions

daily intra abdominal pressures in patients admitted to ICU will be measured and noted for intial 5 days and followed up until end outcome

non survivorssurvivors

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients of acute severe pancreatitis admitted to ICU within 72 hours of symptom onset

You may qualify if:

  • \>Patients with severe acute pancreatitis in the age group of 18-65 years admitted to ICU within 72 hours of onset of symptoms

You may not qualify if:

  • Previous history of any abdominal or pelvic surgery
  • Known case of bladder tumor or bladder abnormality.
  • Difficulty in urinary catheterization
  • Use of neuromuscular blockade
  • Pregnant patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sir Ganga Ram Hospital

New Delhi, National Capital Territory of Delhi, 110060, India

Location

MeSH Terms

Conditions

PancreatitisIntra-Abdominal Hypertension

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesCompartment SyndromesMuscular DiseasesMusculoskeletal DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • vinod singh, MD

    Sir Ganga Ram Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Trainee

Study Record Dates

First Submitted

August 18, 2020

First Posted

August 24, 2020

Study Start

December 26, 2019

Primary Completion

October 20, 2021

Study Completion

October 20, 2021

Last Updated

April 3, 2023

Record last verified: 2023-03

Locations